189 related articles for article (PubMed ID: 31015365)
1. Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p.
Li Z; Hu C; Zhen Y; Pang B; Yi H; Chen X
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015365
[TBL] [Abstract][Full Text] [Related]
2. Pristimerin Suppresses Trophoblast Cell Epithelial-Mesenchymal Transition via miR-542-5p/EGFR Axis.
Shu C; Yu X; Cheng S; Jing J; Hu C; Pang B
Drug Des Devel Ther; 2020; 14():4659-4670. PubMed ID: 33173276
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
Liu F; Gong J; Huang W; Wang Z; Wang M; Yang J; Wu C; Wu Z; Han B
Oncogene; 2014 Oct; 33(40):4813-22. PubMed ID: 24166509
[TBL] [Abstract][Full Text] [Related]
4. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
5. Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis.
Cheng S; Zhang Z; Hu C; Xing N; Xia Y; Pang B
Onco Targets Ther; 2020; 13():6651-6660. PubMed ID: 32753899
[TBL] [Abstract][Full Text] [Related]
6. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1.
Monoe Y; Jingushi K; Kawase A; Hirono T; Hirose R; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Abe Y; Adachi J; Tomonaga T; Tsujikawa K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947152
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D
Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
Ma S; Fu T; Zhao S; Gao M
Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
[TBL] [Abstract][Full Text] [Related]
10. Pristimerin triggers AIF-dependent programmed necrosis in glioma cells via activation of JNK.
Zhao H; Wang C; Lu B; Zhou Z; Jin Y; Wang Z; Zheng L; Liu K; Luo T; Zhu D; Chi G; Luo Y; Ge P
Cancer Lett; 2016 Apr; 374(1):136-148. PubMed ID: 26854718
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
[TBL] [Abstract][Full Text] [Related]
12. IRF7 promotes glioma cell invasion by inhibiting AGO2 expression.
Kim JK; Jin X; Ham SW; Lee SY; Seo S; Kim SC; Kim SH; Kim H
Tumour Biol; 2015 Jul; 36(7):5561-9. PubMed ID: 25680411
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-154-5p inhibits cell proliferation and metastasis by targeting PIWIL1 in glioblastoma.
Wang X; Sun S; Tong X; Ma Q; Di H; Fu T; Sun Z; Cai Y; Fan W; Wu Q; Li Y; Wang Q; Wang J
Brain Res; 2017 Dec; 1676():69-76. PubMed ID: 28842123
[TBL] [Abstract][Full Text] [Related]
14. miR-4725-3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion.
Ho KH; Chang CK; Chen PH; Wang YJ; Chang WC; Chen KC
J Neurochem; 2018 Aug; 146(3):269-288. PubMed ID: 29747239
[TBL] [Abstract][Full Text] [Related]
15. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
16. Pristimerin Induces Autophagy-Mediated Cell Death in K562 Cells through the ROS/JNK Signaling Pathway.
Liu Y; Ren Z; Li X; Zhong J; Bi Y; Li R; Zhao Q; Yu X
Chem Biodivers; 2019 Aug; 16(8):e1900325. PubMed ID: 31290253
[TBL] [Abstract][Full Text] [Related]
17. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
Huang S; He P; Peng X; Li J; Xu D; Tang Y
Cell Physiol Biochem; 2015; 37(1):253-68. PubMed ID: 26302893
[TBL] [Abstract][Full Text] [Related]
18. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
Yan W; Zhang W; Sun L; Liu Y; You G; Wang Y; Kang C; You Y; Jiang T
Brain Res; 2011 Sep; 1411():108-15. PubMed ID: 21831363
[TBL] [Abstract][Full Text] [Related]
19. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
20. Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cells.
Bellissimo T; Tito C; Ganci F; Sacconi A; Masciarelli S; Di Martino G; Porta N; Cirenza M; Sorci M; De Angelis L; Rosa P; Calogero A; Fatica A; Petrozza V; Fontemaggi G; Blandino G; Fazi F
Cell Death Dis; 2019 Jan; 10(1):17. PubMed ID: 30622242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
